News
SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
Discover how the breakthrough pill orforglipron matches injectable weight loss drugs in effectiveness while offering ...
At ASCO, Nucleai will demo their OD-based quantitative biomarker scoring solution, which solves the challenges of manual visual scoring of immunohistochemistry (IHC) images by pathologists, which ...
The parasympathetic nervous system serves as the body’s brake system, promoting rest and digest responses that calm ...
EMA committee recommends approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer: Basel Monday, May 26, 2025, 12:00 Hrs [IST] Roche an ...
Understanding the importance of circadian rhythms in maintaining health and wellness through sleep, diet, and exercise.
19h
MedPage Today on MSNNovel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-LineThe investigational oral agent vepdegestrant more than doubled median progression-free survival (PFS) versus fulvestrant ...
Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...
Bill 26, enacted in December, prohibits doctors from prescribing puberty blockers, hormone therapies to those under 16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results